Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program

BACKGROUND: An intranasal formulation of esketamine, combined with an oral antidepressant, is approved in the USA and the European Union for adults with treatment-resistant depression (TRD). Transient cardiovascular stimulatory effects have been reported with ketamine. METHODS: Cardiovascular effect...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:CNS Drugs
Hoofdauteurs: Doherty, Teodora, Wajs, Ewa, Melkote, Rama, Miller, Janice, Singh, Jaskaran B., Weber, Michael A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2020
Onderwerpen:
Original Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048867/
https://ncbi.nlm.nih.gov/pubmed/31994024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-020-00699-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items